Brianna Abbott

There is more hope than ever for people diagnosed with the deadliest cancer.

Women nationwide will soon learn from test results whether they have dense breast tissue that puts them at higher risk.

Cancer is impacting the finances, relationships and futures of more young people

Vaccines designed to prevent cancer for high-risk groups are in early human trials.

Vaccines designed to prevent cancer for high-risk groups are in early human trials.

More drugs and changing guidelines are too much for general oncologists to track.

More people are navigating the burden of rebuilding lives after cancer.

Cancer survivorship has remarkably increased over the past couple of decades given the significant strides in medicine. Yet, it remains one of the key risks for life expectancy and quality of life in old age. So, it is encouraging to see possibilities of a vaccine for prevention.

When a woman learns she has breast cancer, her reaction is often: take it out. The strategy is akin to one already used in early prostate cancer, as doctors are increasingly looking at whether they can pull back on some cancer therapies, to spare patients side effects and costs. “This is really the first study to confirm our suspicions that there's a subset of low-risk patients that could do just as well without surgery,” said Dr. Nancy Chan, a breast-cancer specialist at NYU Langone's Perlmutter Cancer Center, who wasn't involved in the study.

Women with a type of low-risk cancer might not have to rush aggressive treatment, some doctors say